交易中 09-16 15:31:35 美东时间
+0.030
+1.78%
Ikena Oncology Q2 Operating Income USD -15.823 Million
08-09 04:15
Ikena Oncology Reports Second Quarter 2024 Financial Results
08-09 04:15
Dr. Koehler brings over 20 years of oncology drug development leadership experi...
06-18 19:00
Wedbush has downgraded Ikena Oncology (NASDAQ:IKNA) to neutral, citing Tuesday’s announcement that the company was discontinuing development of its lead asset, IK-930. “While not explicitly stated, we...
05-30 02:22
Gainers: ReShape Lifesciences (RSLS) +84%. Surmodics (SRDX) +20%. Ikena Oncology (IKNA) +17%. Semler Scientific (SMLR) +17%. Immunovant (IMVT) +10%. Losers: Biohaven (BHVN) -27%. Maravai LifeSciences ...
05-29 22:00
Gainers: Siyata Mobile (SYTA) +51%. Cheche Group (CCG) +50%. Brand Engagement Network (BNAI) +32%. Blue World Acquisition (BWAQ) +28%. Globavend Holdings (GVH) +23% Announces MOU to Acquire Top L...
05-29 21:10
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 82.9% to $0.38 ...
05-29 20:06
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 82.9% to $0.38 ...
05-29 20:06
HC Wainwright & Co. analyst Andres Maldonado maintains Ikena Oncology (NASDAQ:IKNA) with a Buy and lowers the price target from $11 to $4.
05-29 18:36